Immune system – vaccine antigens and adjuvants

Immune system – vaccine antigens and adjuvants refers to a broad category of therapeutic components used to elicit a protective or therapeutic immune response. Vaccine antigens are specific molecules, typically derived from pathogens or tumor cells, that are recognized by B and T lymphocytes to establish immunological memory [2]. Adjuvants are supplementary agents included in vaccine formulations to enhance the magnitude, breadth, and durability of the immune response by activating innate immune pathways [1][3]. Together, these components are fundamental to the prevention of infectious diseases and the development of modern immunotherapies for cancer [4]. Their interaction with the immune system involves complex signaling through pattern recognition receptors, such as Toll-like receptors, and the subsequent orchestration of cellular and humoral immunity [3]. This synergistic approach allows for lower doses of antigen and fewer immunizations while achieving robust, long-lasting protection [1].

Other names

Vaccine componentsImmunogens and adjuvantsVaccine delivery systemsImmunostimulatory agents

Vaccine antigens provide the specific epitopes required for B-cell and T-cell recognition, while adjuvants function as 'danger signals' that activate innate immune sensors like Toll-like receptors (TLRs) and the NLRP3 inflammasome [1][3]. This activation promotes the maturation of antigen-presenting cells (APCs), enhances antigen uptake, and modulates the cytokine environment to direct the differentiation of specific T-helper cell subsets [2].